Hantz Financial Services’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-13,233
Closed -$524K – 1074
2021
Q4
$524K Buy
13,233
+3,165
+31% +$144K 0.02% 434
2021
Q3
$504K Buy
10,068
+4,873
+94% +$266K 0.02% 416
2021
Q2
$288K Buy
5,195
+1,744
+51% +$92.9K 0.01% 436
2021
Q1
$161K Buy
+3,451
New +$167K 0.01% 451

Other funds holding HCAT

Hantz Financial Services's HCAT Position: Q1 2022 in Review

Hantz Financial Services sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 13,233 shares — an estimated $524K sold.

Hantz Financial Services first reported a position in HCAT in Q1 2021 and held it in 4 quarters. The position peaked at $524K in Q4 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.

  • Hantz Financial Services reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
  • Hantz Financial Services sold 13,233 Health Catalyst shares in Q1 2022, an estimated $524K.
  • Hantz Financial Services first reported a position in Health Catalyst in Q1 2021 and held it in 4 quarters.
  • Hantz Financial Services's Health Catalyst position peaked at $524K in Q4 2021.
  • 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.

Based on Hantz Financial Services's 13F filing for Q1 2022, filed 23 Aug 2022.